Home Diagnovus

Diagnovus

acquired
Seed Round Financing
A Molecular Diagnostics Provider for Rare Forms of Cancer

Basic Information

Diagnovus, founded in 2011 and headquartered in Nashville, Tennessee, is dedicated to improving patient health and the quality of treatment decisions through truly innovative molecular diagnostics, better informing doctors, patients, and families facing the challenges of these difficult diseases. Their core principles are defined by a passion for service and a commitment to creating evidence-based molecular diagnostic products. By applying these values and principles, they believe they will make a meaningful contribution to improving patient outcomes, helping physicians deliver more effective care, and contributing to the more efficient use of healthcare resources.
Diagnovus
Nashville,Tennessee,United States of America
less than 15 people
January 01, 2011
--